Does MACITENTAN Cause Application site vesicles? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Application site vesicles have been filed in association with MACITENTAN (OPSYNVI). This represents 0.0% of all adverse event reports for MACITENTAN.
14
Reports of Application site vesicles with MACITENTAN
0.0%
of all MACITENTAN reports
1
Deaths
12
Hospitalizations
How Dangerous Is Application site vesicles From MACITENTAN?
Of the 14 reports, 1 (7.1%) resulted in death, 12 (85.7%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Application site vesicles Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MACITENTAN. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does MACITENTAN Cause?
Dyspnoea (8,315)
Death (5,864)
Headache (4,856)
Diarrhoea (3,669)
Pneumonia (3,531)
Nausea (3,463)
Hospitalisation (3,414)
Fatigue (3,172)
Fluid retention (2,861)
Dizziness (2,704)
What Other Drugs Cause Application site vesicles?
INGENOL MEBUTATE (843)
BUPRENORPHINE (700)
SUMATRIPTAN (262)
NICOTINE (241)
MINOXIDIL (188)
ESTRADIOL (179)
FENTANYL (170)
PICATO (139)
DICLOFENAC (115)
CHLORHEXIDINE\ISOPROPYL ALCOHOL (80)
Which MACITENTAN Alternatives Have Lower Application site vesicles Risk?
MACITENTAN vs MACITENTAN\TADALAFIL
MACITENTAN vs MAGNESIUM
MACITENTAN vs MAGNESIUM ASPARTATE
MACITENTAN vs MAGNESIUM ASPARTATE\POTASSIUM ASPARTATE
MACITENTAN vs MAGNESIUM HYDROXIDE